JEEN’s portfolio includes a diverse range of specialized active ingredients, botanical extracts, and complexes serving functional applications for skin and hair care
Alongside brand refresh, the leading clinical trial technology company announces eConsent and eCOA offerings to better support the patient clinical trial journey
The company is investing up to US $ 500 million to produce up to 500 million doses each year for the African continent
Nystatin and Triamcinolone Acetonide ointment is indicated for the treatment of cutaneous candidiasis
Toyobo will start looking at ways to use the knowhow from DMC’s sophisticated fermentation process technologies to enhance the efficiency of making its bioproducts
The expansion is part of Lonza’s continued investment in its global manufacturing network, aiming to build a comprehensive offering for global customers
Expanding the Applied Biosystems portfolio with the latest generation of innovative, mid-throughput genetic analyzers
OxemiaTM (Desidustat) is an oral tablet formulation that is the first-in-India alternative to injectable erythropoietin-stimulating agents (ESAs)
Taisho Pharmaceutical will bring its experience and expertise in the research and development of therapeutic products to the collaboration.
Around 85% of ALS patients suffer from a progressive loss of bulbar functionality
Subscribe To Our Newsletter & Stay Updated
